TrialJournal of clinical immunology2025

A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.

William R Lumry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.